ZURICH/BERLIN, June 21 (Reuters) - Here are some of the main
factors that may affect Swiss stocks on Monday:
CORONAVIRUS
Switzerland plans to allow 12- to 15-year olds to receive
vaccinations against COVID-19 as soon as next week, government
vaccine chief Christoph Berger told Swiss newspaper NZZ in an
interview published on Sunday.
COMPANY STATEMENTS
* Novartis NOVN.S said new data for Zolgensma, its
one-time treatment for spinal muscular atrophy, found children
given the gene therapy before they developed symptoms had
age-appropriate development. NOVN.S
* HBM HBMN.S said its portfolio company Ambrx Biopharma
raised $126 million in an initial public offering. HBMN.S
* Peach Property